SCHEMBL1126265

SCHEMBL1126265

CC(C)(C)OC(=O)Nc1ccc(CO)cn1.[AlH3].[LiH]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.48
HDAC1 Q13547 1/20 0.48
GRIN2B Q13224 1/20 0.44
CYP17A1 P05093 1/20 0.43
GSK3B P49841 1/20 0.41
DYRK1A Q13627 1/20 0.41
LCK P06239 1/20 0.40
SCN9A Q15858 1/20 0.40
MAPKAPK2 P49137 2/20 0.39
BCL2 P10415 1/20 0.39
ATR Q13535 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
DEGS1 O15121 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
MAPK14 Q16539 1/20 0.37
RAB9A P51151 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL540536 0.97 NAMPT (0.50) NAMPTHDAC1GRIN2BCYP17A1GSK3B
SCHEMBL15354526 0.86 NAMPT (0.50) NAMPTHDAC1GRIN2BCYP17A1GSK3B
SCHEMBL10087556 0.84 NAMPT (0.49) NAMPTHDAC1GRIN2BCYP17A1GSK3B
SCHEMBL164105 0.84 HDAC1 (0.52) NAMPTHDAC1GRIN2BCYP17A1GSK3B
SCHEMBL21394710 0.84 NAMPT (0.49) NAMPTHDAC1GRIN2BCYP17A1GSK3B
SCHEMBL29523504 0.84 HDAC1 (0.52) NAMPTHDAC1GRIN2BCYP17A1GSK3B
SCHEMBL9980800 0.84 NAMPT (0.49) NAMPTHDAC1GRIN2BCYP17A1GSK3B
SCHEMBL540467 0.84 NAMPT (0.49) NAMPTHDAC1GRIN2BCYP17A1GSK3B
SCHEMBL13456709 0.83 NAMPT (0.53) NAMPTHDAC1GRIN2BCYP17A1GSK3B
SCHEMBL27947682 0.83 NAMPT (0.48) NAMPTHDAC1GRIN2BCYP17A1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS Novartis AG (CH) 2011-02-16 EP disclosed
WO-2009141386-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2009-11-26 WO disclosed